Ginkgo Biloba
Ginkgo has seizure case reports and is undesirable in patients taking antiseizure medication.
Recommendation: Avoid ginkgo in patients with epilepsy unless the neurologist approves.
Prescription ·Strong evidence ·Reviewed May 2026
Oxcarbazepine is an anticonvulsant used for focal seizures and sometimes off-label for mood stabilization. Its most clinically important nutrition-adjacent safety issue is hyponatremia, which can be symptomatic and severe. It also induces CYP3A4 and UGT pathways enough to reduce exposure to some drugs, including hormonal contraceptives.
The bottom line
Evidence rating strong. Most-documented uses: monotherapy or adjunctive treatment of focal-onset seizures, reduction in seizure frequency, off-label specialist use in selected bipolar-spectrum patients. 3 sources indexed (2013–2026), with 4 interaction records on file.
Core mechanism
Oxcarbazepine is rapidly converted to the active monohydroxy derivative, which stabilizes hyperexcited neuronal membranes mainly by blocking voltage-sensitive sodium channels. This reduces repetitive neuronal firing and synaptic seizure propagation. The drug can promote inappropriate antidiuretic hormone physiology or renal water retention, leading to dilutional hyponatremia, and it can induce CYP3A4/5 and UGT enzymes while inhibiting CYP2C19.1,2
Immediate-release oxcarbazepine may be taken with or without food. Extended-release products should be taken consistently as labeled, often on an empty stomach for Oxtellar XR.
Nutrients this medication can lower over time, and what to replace.
Oxcarbazepine can cause dilutional hyponatremia through antidiuretic hormone-like effects and impaired free-water handling, lowering serum sodium rather than depleting total body sodium in many cases.
Ginkgo has seizure case reports and is undesirable in patients taking antiseizure medication.
Recommendation: Avoid ginkgo in patients with epilepsy unless the neurologist approves.
Melatonin may add to oxcarbazepine-related dizziness and somnolence.
Recommendation: Use cautiously and monitor for falls or next-day impairment.
Ashwagandha may cause sedation and could add to oxcarbazepine CNS effects.
Recommendation: Use cautiously, especially during dose changes or if dizziness is present.
St. John's Wort is an inducer of CYP3A4 and P-glycoprotein. Oxcarbazepine also induces CYP3A4, so the combination can amplify interaction burden for other medications.
Recommendation: Avoid unless the clinician has reviewed all medications, especially hormonal contraceptives, anticoagulants, immunosuppressants, and psychiatric drugs.
Numbered references. Citations throughout the page link here.
Review emphasizes severe hyponatremia risk and relevant contraindication/caution populations.
Guideline review supports oxcarbazepine efficacy in focal seizure treatment while noting tolerability limitations.
Labeling describes recommended seizure dosing, renal adjustment, hyponatremia warning, skin reactions, and enzyme-induction interactions.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.